Strategic Medicine’s mission is to improve clinical outcomes through better patient and disease stratification. The company addresses a fundamental problem in medicine that is increasingly problematic for patients, healthcare providers, and payers alike.

SMI offers disease stratification products and services driven by clinical need and supported by its rapidly expanding knowledge base and improved implementation of diagnostic technology.

Watch a video interview with SMI's President Michael Liebman: